As per our research report, the global breast biopsy market size is estimated to be growing at a CAGR of 10.91% from 2022 to 2027 and grow to USD 1104.89 million by 2027 from USD 658.36 million in 2022.
Browse details of the report @ https://www.marketdataforecast.com/market-reports/breast-biopsy-market
A biopsy is a surgical operation that involves removing tissue from an organ. The method determines whether a disease, such as inflammatory or malignant diseases, exists. For example, a breast biopsy is a screening procedure that determines the location of abnormal tissue growth or the presence of malignant cells in the breast. Devices such as vacuum-assisted biopsy, core needle biopsy, and fine needle biopsy are used to find defects or abnormalities in cells. Assist the surgeons or radiologists doing the biopsy with specialist imaging equipment such as ultrasound, mammography-guided stereotactic biopsy with x-ray, and others.
The COVID-19 pandemic is having a negative impact on market growth. Breast cancer biopsy services suffered a lot of unfavorable implications because of the pandemic. Hospitals, clinics, and diagnostic institutions could not provide biopsy services due to lockdowns in various countries to prevent the spread of COVID-19. In addition, the pandemic reduced the amount of breast cancer screenings. However, the market has begun to recover and is expected to return to normal soon. However, because of the relaxation of regulations, a surge in the number of biopsies is projected in the post-COVID-19 period.
Increased sensitivity of women to mammary cancer in all countries and awareness programs and screenings in their favor all contribute to the expansion of the breast biopsy market. In addition, the development of more accurate and minimally invasive methods for early detection of breast cancer has benefitted the biopsy market’s growth. Governments have also supported the development of these diagnostic tools by attempting to promote a stable and comprehensive environment for cancer research. Furthermore, favorable reimbursements have considerably improved the sector’s health.
Overconsumption of alcoholic drinks, lack of physical activity, poor nutrition and eating habits, hormonal imbalance, and skin exposure to harsh sunlight are all factors that contribute to the growth in breast cancer incidence. To boost efficiency, the leading players are mainly focusing on technical developments. This market’s long-term growth patterns can be achieved by maintaining existing development trends and having the financial resources to participate in the most effective methods. The latest advancements in 3D scanning technology are causing a stir in the breast biopsy market. 3D image-guided breast biopsies with a prone system are available at CareMount Medical in New York. Radiologists can access lesions without relocating the patient because of the 360° view. In addition, they added a software improvement that uses color mapping technology to provide the best identification of abnormal regions on a breast MRI.
The patient may feel moderate pain, bruising, and bleeding at the biopsy site during or after the surgery, limiting market expansion. Neck pain during a stereotactic treatment and arm pain during an ultrasound operation are two other possible side effects of image-guided biopsies. Furthermore, concerns over product recalls are projected to hamper market expansion. In addition, the risk of infections is expected to pose a challenge to the breast biopsy equipment market. However, inadequate awareness among females and poor healthcare facilities, particularly in developing countries, are limiting the growth of the breast biopsy market.
Avail sample market brochure of the report to evaluate report usefulness; get a copy @ https://www.marketdataforecast.com/market-reports/breast-biopsy-market/request-sample
SEGMENTS COVERED UNDER THIS REPORT:
- Biopsy needles
- Guidance systems
- Biopsy tables
- Localization wires
- Needle Breast Biopsy
- Core Needle Biopsy
- Fine Needle Aspiration Biopsy
- Vacuum-Assisted Biopsy
- Open Surgical Breast Biopsy
- Excisional Breast Biopsy
- Incisional Breast Biopsy
- Mammography-Guided Stereotactic Breast Biopsy
- Ultrasound-Guided Breast Biopsy
- MRI-Guided Breast Biopsy
- Other Guidance Techniques
- North America
- The U.S.
- Rest of North America
- Rest of EU
- Asia Pacific
- South Korea
- Australia & New Zealand
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East
KEY MARKET INSIGHTS:
Based on the product, due to the increased use of image-guided techniques in both developed and developing nations and the introduction of technologically advanced and unique designs, the biopsy needles segment is likely to hold a significant share of the breast biopsy market. The tri-axial needle, for example, is made up of a pincer needle on the outside, an outer cutting needle, and a sharp stylet on the inside. Healthcare practitioners may cut through tissue without squeezing it because of the needle design. In addition, due to its unique design, the needle is visible under ultrasonography and CT, which are routinely used for biopsy guidance.
Based on technology, the ultrasound-guided method produces more precise results and is expected to increase at the fastest rate during the research.
Based on end-user, hospitals and clinics held the most significant market share because of the rising number of breast cancer patients worldwide. Furthermore, trained doctors frequently perform the biopsy in hospitals, making hospitals a popular location for biopsies. Moreover, a breast biopsy involves the removal of a small piece of tissue by a needle or surgery.
Geographically, during the forecast period, the North American breast biopsy needle market is expected to increase. An increase in cancer incidence increased awareness about early detection and treatment, and technological developments are all contributeregion’s growth. In addition, because of the increased aging population, high healthcare spending, economic affluence, and the expanding private healthcare sector, the use of breast biopsy instruments are much higher in the United States. Furthermore, federal, state, and local governments, voluntary healthcare associations, pharmaceutical, and biotechnology companies, professional societies, and research institutions in the United States heavily invest in various medical and health-related research and development activities, which aids the market’s growth.
The European breast biopsy needle market is expected to increase during the forecast period. An increase in the number of cancer patients, increasing government investment in research and development activities, and technological developments contribute to this region’s growth.
The Asia Pacific breast biopsy needle market is expected to grow due to factors such as rising demand from emerging countries such as India and China, an aging population base leading to an increase in the incidence rate of cancer among women, rapid economic development leading to improved standards of living resulting in increased awareness about health care facilities, and high disposable income levels due to increased employment opportunities, among others.
The market for breast biopsy needles in Latin America is likely to expand. The rising prevalence of cancer, the growing demand for better diagnostic facilities, and government activities for cancer control programs contribute to the region’s rise.
Ethicon Endo-Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, and Encapsule Medical Devices LLC are some of the notable companies operating in the global breast biopsy market profiled in this report.
The report can be customized as per the requirements; talk to our team @ https://www.marketdataforecast.com/market-reports/cold-plasma-market/customization
Browse Related Reports:
- North America Breast Biopsy Market
- Europe Breast Biopsy Market
- APAC Breast Biopsy Market
- Latin America Breast Biopsy Market
- MEA Breast Biopsy Market
Market Data Forecast is a firm working in market research, business intelligence, and consulting. We have rich research and consulting experience for various business domains to cater to individual and corporate clients’ needs.
Market Data Forecast